Fraser Brims

Dr. Fraser Brims serves as a Clinical Associate Professor at the University of Western Australia Medical School within the Centre for Respiratory Health. His academic work is deeply integrated with clinical practice and research in respiratory medicine, particularly focusing on lung cancer and asbestos-related diseases. His institutional affiliations include the National Centre for Asbestos Related Diseases and the Lung Cancer Clinical Quality Data Platform (LUCAP) in Western Australia.

Brims' research interests span lung cancer screening, mesothelioma, low-dose CT imaging, and asbestos-related diseases. His work significantly contributes to Sustainable Development Goals related to good health and well-being. He has developed expertise in managing screen-detected nodules and has been instrumental in establishing clinical quality indicators for thoracic cancer care across Australasia. His research bridges clinical practice with population health approaches to improve early detection and management of respiratory cancers.

His recent publications demonstrate a strong focus on lung cancer screening implementation, with particular attention to risk assessment, incidental findings in CT imaging, and long-term outcomes of asbestos exposure. Brims has contributed to developing practical clinical guidelines for managing pulmonary nodules and establishing quality metrics for thoracic cancer care through consensus processes.

Brims is actively involved in multiple research projects, including leading the Support for the Lung Cancer Clinical Quality Data Platform (LUCAP) through the Western Australia Department of Health (2025-2028) and serving as an investigator in the National Centre for Asbestos Related Diseases. His other significant projects include research on palliative care for mesothelioma, ultra low dose CT in silicosis screening, and comparative imaging studies for silicosis detection.

His collaborative network spans Australia and Canada, with significant contributions to international lung cancer screening initiatives. Brims works closely with major institutions including Sir Charles Gairdner Hospital, Royal Perth Hospital, and Insurance & Care NSW, demonstrating strong translational research capabilities connecting academic medicine with clinical practice and health policy.